MENU
+Compare
BLRX
Stock ticker: NASDAQ
AS OF
Jul 16, 04:49 PM (EDT)
Price
$4.57
Change
+$0.05 (+1.11%)
Capitalization
16.71M

BLRX BioLineRx Ltd Forecast, Technical & Fundamental Analysis

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology... Show more

BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BLRX with price predictions
Jul 15, 2025

BLRX saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for BLRX moved out of overbought territory on July 15, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 42 similar instances where the indicator exited the overbought zone. In of the 42 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BLRX moved out of overbought territory on June 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BLRX as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BLRX turned negative on June 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BLRX broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BLRX advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 62 cases where BLRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BLRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.806) is normal, around the industry mean (17.548). P/E Ratio (0.000) is within average values for comparable stocks, (58.754). BLRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.452). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.499) is also within normal values, averaging (269.838).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BLRX is expected to report earnings to rise 50.00% to -2 cents per share on March 26

BioLineRx Ltd BLRX Stock Earnings Reports
Q4'24
Est.
$-0.03
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.14
Q1'24
Beat
by $0.16
Q4'23
Beat
by $0.01
The last earnings report on November 25 showed earnings per share of -1 cents, beating the estimate of -5 cents. With 8.43K shares outstanding, the current market capitalization sits at 16.71M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical development company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2 HaMa’ayan Street
Phone
+972 86429100
Employees
79
Web
https://www.biolinerx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MIRA1.660.12
+7.79%
MIRA Pharmaceuticals
RJF156.27-3.04
-1.91%
Raymond James Financial
ENOV30.90-1.06
-3.32%
Enovis Corp
THRY11.82-0.61
-4.91%
Thryv Holdings
ALTO1.19-0.07
-5.56%
Alto Ingredients

BLRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with PYXS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
-3.83%
PYXS - BLRX
42%
Loosely correlated
-2.52%
KURA - BLRX
35%
Loosely correlated
-3.46%
DWTX - BLRX
33%
Loosely correlated
-7.48%
TAOX - BLRX
30%
Poorly correlated
-6.60%
AEON - BLRX
29%
Poorly correlated
-4.25%
More